Economic Burden of COPD by Disease Severity - A Nationwide Cohort Study in Denmark.

In this nationwide real-world study, total direct costs were three-fold higher among patients with COPD compared with the reference population. Severe exacerbations were a major driver of the direct costs. The costs increased with increasing disease severity.